Dr. Victor M. Amato, MD

Dr. Amato practices at MUSC Health Lancaster Medical Center in Lancaster, South Carolina, part of Medical University of South Carolina.

Dr. Amato's NPI, 1053325076, was assigned on July 27, 2006. Dr. Amato holds South Carolina license 23433.

Dr. Amato's primary practice is MUSC Health Lancaster Medical Center, at 800 W Meeting St, Lancaster, SC 29720 in Lancaster County. The practice phone is (803) 286-1481.

Dr. Amato's primary practice is MUSC Health Lancaster Medical Center in Lancaster, South Carolina, part of Medical University of South Carolina. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Amato to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amato practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Amato's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Amato is board certified in internal medicine by the American Board of Internal Medicine. Dr. Amato is licensed in South Carolina.

CMS data shows 132 Medicare services from Dr. Amato across 2 procedure codes in 2024, for 100 Medicare patients. Medicare paid $9,322 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Amato in 2024. The largest group is 75 to 84, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amato's median patient age at 63, with 57% women.

In 2021, Dr. Amato wrote 567 Medicare Part D claims. They cover 12 drugs, with $148,974 in total drug cost. In 2020, CMS named 3,144 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Amato for performance year 2024, reported as part of a group.

CMS Open Payments shows 423 general payments to Dr. Amato from 27 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,707.